首页> 外文期刊>Breast cancer >Breast implant-associated anaplastic large-cell lymphoma: first case detected in a Japanese breast cancer patient
【24h】

Breast implant-associated anaplastic large-cell lymphoma: first case detected in a Japanese breast cancer patient

机译:乳腺植入植入性促进式大细胞淋巴瘤:在日本乳腺癌患者中检测到的第一个病例

获取原文
获取外文期刊封面目录资料

摘要

This paper details the first breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) case detected in Japan. The patient, a 67-year-old Japanese woman, was diagnosed with left unilateral breast cancer 17?years ago. Induration and redness presented in the left breast, which had undergone immediate breast reconstructive surgery using a tissue expander, later replaced by a silicone breast implant (SBI). Breast ultrasound showed fluid collection around the SBI. Surgery was performed to remove the left breast implant and the fragmented capsule surrounding the implant. Postoperative pathological findings did not indicate malignancy. Nine months later, a contralateral axillary lymphadenopathy was observed, and an excisional biopsy of the axillary lymph node was performed. The patient was diagnosed with BIA-ALCL and successfully underwent adjuvant CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone) chemotherapy.
机译:本文详述了在日本检测到的第一个乳房植入物相关的anaplastic大细胞淋巴瘤(BIA-ALCL)病例。患者是一名67岁的日本女性,被诊断出患有左侧单侧乳腺癌17岁?几年前。在左乳房呈现的硬结和发红,其使用组织扩展器经历了立即乳房重建手术,后来被硅氧烷乳房植入物(SBI)所取代。乳房超声显示SBI周围的流体收集。进行手术以除去左乳房植入物和植入物周围的碎片胶囊。术后病理发现并未表明恶性肿瘤。九个月后,观察到对侧腋窝淋巴结病,进行腋窝淋巴结的切除活检。患者被诊断为BIA-ALCL,并成功地进行了佐剂斩波(环磷酰胺,多亮枯素,长胆碱和泼尼松龙)化疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号